These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 12660689)
21. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681 [TBL] [Abstract][Full Text] [Related]
22. Tenecteplase for acute ischemic stroke. Lyden P Int J Stroke; 2011 Dec; 6(6):509-10. PubMed ID: 22111795 [No Abstract] [Full Text] [Related]
23. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. Cucchiara B; Tanne D; Levine SR; Demchuk AM; Kasner S J Stroke Cerebrovasc Dis; 2008; 17(6):331-3. PubMed ID: 18984422 [TBL] [Abstract][Full Text] [Related]
24. Thrombolysis in dementia patients with acute stroke: is it justified? Paciaroni M; Pantoni L Neurol Sci; 2017 Jan; 38(1):27-31. PubMed ID: 27699498 [TBL] [Abstract][Full Text] [Related]
25. Application of a medicolegal approach in clinical stalemates. Tang M J Med Ethics; 2012 Nov; 38(11):645-6. PubMed ID: 22923440 [No Abstract] [Full Text] [Related]
26. Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke. Dharmasaroja PA; Muengtaweepongsa S; Pattaraarchachai J; Dharmasaroja P J Clin Neurosci; 2012 Jun; 19(6):799-803. PubMed ID: 22472785 [TBL] [Abstract][Full Text] [Related]
27. SITS-MOST: old myths laid to rest. Hallevi H; Grotta JC Lancet Neurol; 2007 Apr; 6(4):292-3. PubMed ID: 17362829 [No Abstract] [Full Text] [Related]
28. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke. Messé SR; Pervez MA; Smith EE; Siddique KA; Hellkamp AS; Saver JL; Bhatt DL; Fonarow GC; Peterson ED; Schwamm LH Stroke; 2013 May; 44(5):1354-9. PubMed ID: 23493734 [TBL] [Abstract][Full Text] [Related]
29. Safety outcomes of Alteplase among acute ischemic stroke patients with special characteristics. Sylaja PN; Dong W; Grotta JC; Miller MK; Tomita K; Hamilton S; Semba C; Hill MD Neurocrit Care; 2007; 6(3):181-5. PubMed ID: 17572861 [TBL] [Abstract][Full Text] [Related]
30. Thrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage. Reuter B; Grudzenski S; Chatzikonstantinou E; Meairs S; Ebert A; Heiler P; Schad LR; Staufenbiel M; Hennerici MG; Fatar M Stroke; 2014 Aug; 45(8):2411-6. PubMed ID: 25005438 [TBL] [Abstract][Full Text] [Related]
31. Intravenous thrombolytic therapy for acute ischemic stroke. Wechsler LR N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326 [No Abstract] [Full Text] [Related]
32. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. Derex L; Hermier M; Adeleine P; Pialat JB; Wiart M; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P; Nighoghossian N J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):70-5. PubMed ID: 15607998 [TBL] [Abstract][Full Text] [Related]
33. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study. Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718 [TBL] [Abstract][Full Text] [Related]